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echanisms for activating the actin-related protein
2/3 (Arp2/3) complex have been the focus of
many recent studies. Here, we identify a novel
mode of Arp2/3 complex regulation mediated by the highly
conserved actin binding protein coronin. Yeast coronin
(Crn1) physically associates with the Arp2/3 complex and
inhibits WA- and Abp1-activated actin nucleation in vitro.
The inhibition occurs speciﬁcally in the absence of preformed
actin ﬁlaments, suggesting that Crn1 may restrict Arp2/3
complex activity to the sides of ﬁlaments. The inhibitory
activity of Crn1 resides in its coiled coil domain. Localization
of Crn1 to actin patches in vivo and association of Crn1
M
 
with the Arp2/3 complex also require its coiled coil domain.
Genetic studies provide in vivo evidence for these interactions
and activities. Overexpression of 
 
CRN1
 
 causes growth arrest
and redistribution of Arp2 and Crn1p into aberrant actin
loops. These defects are suppressed by deletion of the Crn1
coiled coil domain and by 
 
arc35-26,
 
 an allele of the p35
subunit of the Arp2/3 complex. Further in vivo evidence
that coronin regulates the Arp2/3 complex comes from the
observation that 
 
crn1
 
 and 
 
arp2
 
 mutants display an allele-
speciﬁc synthetic interaction. This work identiﬁes a new
form of regulation of the Arp2/3 complex and an important
cellular function for coronin.
 
Introduction
 
Many cellular processes, including cell locomotion, vesicle
and organelle transport, endocytosis, cytokinesis, and polarized
cell growth, require dynamic remodeling of the actin cyto-
skeleton. All of these processes involve spatially controlled
assembly and reorganization of actin networks in response to
cellular cues. However, the exact mechanisms regulating
these spatial and temporal changes are not well understood.
In recent years, the actin-related protein 2/3 (Arp2/3)* complex
has emerged as a central effector of actin assembly that receives
multiple signal inputs (for review see Higgs and Pollard, 2001).
The Arp2/3 complex is composed of seven evolutionarily
conserved subunits: two actin-related proteins (Arp2 and
Arp3) and five other subunits, which in yeast are called
Arc40, Arc35, Arc18, Arc19, and Arc15. In all organisms
examined, the Arp2/3 complex localizes to sites of dynamic
actin assembly. In yeast, the Arp2/3 complex localizes to
cortical actin patches, highly motile filamentous actin structures
(for reviews see Pruyne and Bretscher, 2000; Goode and
Rodal, 2001). Mutations in different subunits of the yeast
Arp2/3 complex disrupt actin organization, actin patch
motility, and actin-dependent processes such as endocytosis,
cell polarity development, and organelle inheritance (for review
see Goode and Rodal, 2001).
 
The Arp2/3 complex has two established and apparently
coupled activities, actin nucleation and actin filament
branching (for reviews see Cooper et al., 2001; Borths and
Welch, 2002; Kreishman-Deltrick and Rosen, 2002). The
Arp2/3 complex can bind to the side of an existing
(mother) filament and nucleate the formation of a new
 
(daughter) filament at a 70
 
 
 
 angle, leading to the formation
of branched filament networks (Mullins et al., 1998).
Alone, the Arp2/3 complex has relatively weak actin nucleation
activity. Activation is achieved by two complementary
mechanisms: (1) association of the complex with the side of
an actin filament and (2) interactions with an activator protein,
such as SCAR/WASp, myosin I, Abp1, cortactin, and Pan1
(for reviews see Olazabal and Machesky, 2001; Schafer, 2002).
Coronin is a conserved component of the actin cytoskeleton
found in all eukaryotes examined from yeast to mammals,
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where it localizes to sites of dynamic actin assembly (for re-
view see de Hostos, 1999). In budding yeast, coronin-null
mutants have no overt phenotype, but overexpression of the
coronin gene (
 
CRN1)
 
 is lethal and disrupts actin organiza-
tion. In addition, genetic interactions with 
 
act1-159
 
 and 
 
cof1-
22
 
 suggest that Crn1 regulates some aspect of actin assembly
and/or turnover (Goode et al., 1999). In 
 
Dictyostelium discoi-
deum
 
, coronin mutants display defects in cell migration, cy-
tokinesis, phagocytosis, and fluid phase endocytosis (de Hos-
tos et al., 1993). In cultured 
 
Xenopus
 
 cells, overexpression of a
coronin fragment causes severe defects in cell migration and
spreading (Mishima and Nishida, 1999).
The biochemical properties of coronin support the notion
that it regulates actin assembly and organization. In vitro, pu-
rified coronin binds specifically to filamentous actin, bundles
actin filaments, and weakly promotes actin assembly (Goode
et al., 1999; Asano et al., 2001). The amino terminus of coro-
nin contains five to six 
 
 
 
-propeller–like WD repeats that
form the actin binding domain (Goode et al., 1999). The car-
boxy terminus is comprised of a “unique” region, which is
highly variable among species, and a short conserved coiled
coil domain (residues 603–651 in yeast coronin). The coiled
coil domain is required for coronin dimerization and actin fil-
ament bundling in vitro (Goode et al., 1999; Asano et al.,
2001). In 
 
Xenopus
 
 cells, deletion of the coiled coil domain
causes mislocalization of coronin, suggesting that dimeriza-
tion, or other interactions of the coiled coil domain, is neces-
sary for its proper localization and function (Mishima and
Nishida, 1999). However, the exact function of coronin
within the actin cytoskeleton has remained unclear.
Here, we identify a molecular function for yeast coronin
(Crn1). We provide multiple lines of biochemical and ge-
netic evidence that Crn1 associates with and regulates the
Arp2/3 complex through an interaction of its coiled coil do-
main. These studies reveal an important cellular function for
Crn1 and novel aspects of Arp2/3 complex regulation.
 
Results
 
Crn1 physically associates with the Arp2/3 complex
 
To better understand the cellular function of yeast coronin
(Crn1), we sought to identify Crn1-interacting partners.
Wild-type cell extracts were fractionated on sucrose gradi-
ents by velocity sedimentation and the migration patterns of
actin, Crn1, and numerous other actin-associated proteins
were determined by immunoblotting. Fig. 1 A shows the
data for actin, Crn1, and Arp2p (a component of the Arp2/3
complex). The vast majority of actin (43 kD) migrated to a
position consistent with actin monomers. Crn1 migration
had two distinct peaks, with 
 
 
 
40% of the Crn1 peaking at
a position consistent with Crn1 monomers (72 kD) and
 
 
 
60% of the Crn1 peaking at a position suggesting a
complex of 250–300 kD. Immunoblotting with antibodies
against numerous actin-associated proteins (Aip1, Cof1,
Cap2, Pfy1, Sac6, Sla2, Srv2, Tpm1, and Twf1; unpub-
lished data) revealed that only one, Arp2, comigrated with
Crn1 in the 250–300-kD range. This raised the possibility
that Crn1 and the Arp2/3 complex physically associate.
Next, we tested the ability of Crn1 to coimmunoprecipi-
tate with the Arp2/3 complex from cell lysates. We inte-
grated an epitope tag (3xHA) at the carboxy terminus of
 
ARP2
 
. The tagged protein was the only source of Arp2p in
cells and fully complemented growth at 16–37
 
 
 
C with no
visible defects in actin organization (unpublished data). To
control for potential nonspecific interactions from coprecip-
itation of actin filaments with the Arp2/3 complex, we in-
cluded 40 
 
 
 
M latrunculin A in the immunoprecipitation re-
actions. Immunoblotting confirmed the absence of actin in
the pellets (unpublished data). As shown in Fig. 1 B, over
half of the Crn1 in cells coimmunoprecipitated with the
Arp2/3 complex, similar to the fraction of Crn1 that comi-
grated with the Arp2/3 complex in sucrose gradients (Fig. 1
A). Thus, by two independent approaches (velocity sedi-
mentation and coimmunoprecipitation), Crn1 was found to
associate with the Arp2/3 complex.
As an additional test of the interaction, we compared Arp2
migration in extracts from wild-type and 
 
crn1
 
-null cells frac-
Figure 1. Crn1 physically associates with the Arp2/3 complex. 
(A) Comigration of Crn1 and Arp2 by sedimentation velocity. Yeast 
cell lysates were fractionated on sucrose gradients by overnight high 
speed centrifugation, and then fractions were collected. Samples of 
each fraction were blotted and probed with antibodies for yeast 
actin, Crn1, and Arp2. Size standards were fractionated in parallel: 
BSA (60 kD), Catalase (240 kD), and Thyroglobulin (760 kD). 
(B) Coimmunoprecipitation of Crn1 with Arp2–HA. Yeast cell lysates 
expressing a carboxy-terminal–tagged Arp2–HA fusion protein were 
incubated with anti-HA antibody–coated beads ( ) or control beads 
with no antibody ( ). Beads were pelleted, and equivalent loads of 
pellets and supernatants were blotted and probed with anti-Crn1 or 
anti-Arp2 antibodies. (C) Comparison of Arp2 migration in wild-type 
and crn1-null cell extracts fractionated by sedimentation velocity. 
Arp2 signal was quantified by immunoblotting and densitometry. 
The distribution was compared for wild-type and crn1-null yeast 
extracts fractionated on sucrose gradients. 
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tionated on sucrose gradients. Arp2 migration exhibited a
substantial shift and narrowing of its peak in the 
 
crn1
 
-null ly-
sate, consistent with a loss of mass from a large subset of the
Arp2/3 complex in cells (Fig. 1 C). We have determined that
Crn1 and the Arp2/3 complex have a similar abundance in
yeast (Arp2/3 complex is slightly more abundant than Crn1;
unpublished data). This, combined with the data in Fig. 1 C,
indicates that 
 
 
 
25% of the cellular pool of the Arp2/3 com-
plex is stably associated with Crn1.
Next, we tested if the Crn1–Arp2/3 complex interaction is
direct. To accomplish this, we purified HA-tagged Arp2/3
complex on HA antibody–coated beads (Fig. 2). The beads
were washed in high salt to remove Arp2/3 complex–associ-
ated factors, such as coronin, Abp1, and Las17. The purified
material has the characteristic gel band pattern of the Arp2/3
complex subunits. Further, mass spectrometry analysis of
the complex released from beads verifies that it is the Arp2/3
complex, and the released complex is active in promoting ac-
tin nucleation (unpublished data). As shown in Fig. 2, puri-
fied Crn1 binds to HA–Arp2/3 complex beads, but not to
control beads (HA antibody, but no Arp2/3 complex). This
demonstrates that the Crn1–Arp2/3 complex interaction is
direct. The binding saturated at a molar stoichiometry of
 
 
 
1:1 Crn1 to Arp2/3 complex, and the addition of higher
concentrations of Crn1 to the reactions did not increase the
amount of Crn1 bound (unpublished data).
 
The coiled coil domain of Crn1 is required for 
association with the Arp2/3 complex and Crn1 
localization in vivo
 
In a two hybrid screen using the Arc35/p35 subunit of the
Arp2/3 complex as bait, we identified a specific interaction
with a carboxy-terminal fragment of Crn1. Sequencing of
two independently selected plasmids revealed the same frag-
ment of Crn1, encoding residues 466–651 (see Materials
and methods). This raised the possibility that the carboxy
terminus of Crn1 might be important for mediating physical
interactions with the Arp2/3 complex. To test this hypothe-
sis, we examined the ability of Crn1 fragments to coimmu-
noprecipitate with the Arp2/3 complex. Low copy plasmids
expressing fragments of Crn1 were transformed into a 
 
crn1
 
-
null strain carrying a 3xHA epitope tag integrated at the car-
boxy terminus of 
 
ARP2
 
. Cell lysates from these strains were
used for immunoprecipitation assays. Full-length Crn1,
Crn1 (1–600), and Crn1 (400–651) were expressed to simi-
lar levels (Fig. 3 A; whole cell extract blot). As shown in Fig.
3 A, Crn1 and Crn1 (400–651) coimmunoprecipitated with
the Arp2/3 complex, but Crn1 (1–600) did not. These data
show that the coiled coil domain–containing carboxy termi-
nus of Crn1 is both required and sufficient for association
with the Arp2/3 complex in vivo.
Next, we examined the localization of Crn1 and Crn1
fragments in cells by immunofluorescence with anti-Crn1
antibodies. Crn1 localized to actin patches, as expected, but
Crn1 (1–600) and Crn1 (400–651) localized primarily to
the cytoplasm, with only faint residual actin patch staining
(Fig. 3 B). The localization of Crn1 (1–600) to the cyto-
plasm was unexpected, given that this construct binds to ac-
tin filaments in vitro (Goode et al., 1999), and prompted
us to examine the localization patterns of Crn1 and Crn1
(1–600) by an independent approach. We integrated GFP tags
at the 
 
CRN1
 
 locus carboxy terminus after the codons for res-
idues 600 and 650, generating strains that express Crn1–
GFP and Crn1 (1–600)–GFP fusion proteins, respectively.
Immunoblotting with Crn1 and GFP antibodies confirmed
that these constructs were expressed at normal levels and
were the only source of Crn1 in cells (unpublished data). As
shown in Fig. 3 C, Crn1–GFP localizes to cortical actin
patches, and Crn1 (1–600)–GFP localizes primarily to the
cytoplasm, confirming the immunofluorescence data. These
results demonstrate that neither the actin binding domain
nor the Arp2/3 complex–interacting carboxy terminus of
Crn1 is sufficient for localization in vivo.
 
The coiled coil domain is required for defects 
in actin organization and cell growth 
caused by Crn1 overproduction
 
Deletion of the 
 
CRN1
 
 gene in yeast causes no overt growth
phenotype or defects in actin organization (Heil-Chapde-
laine et al., 1998; Goode et al., 1999). However, as shown in
Fig. 4 A, galactose promoter–driven overexpression of un-
tagged Crn1 causes severe defects in actin organization and
arrest of cell growth. Cells overproducing Crn1 are swollen,
have depolarized actin patches, and form spiraled or looped
actin structures (Fig. 4 B). The actin loops do not appear to
be cable like, because they do not label with tropomyosin
antibodies (a cable-specific marker) and they form in the ab-
sence of any functional formin proteins, Bnr1 and Bni1 (un-
published data). The actin loops also are distinct from the
actin bars formed in cells overproducing a GST–Crn1 fu-
sion protein (Goode et al., 1999), because unlike the bars,
the loops label with rhodamine phalloidin. These aberrant
actin loops were detected in 36% of cells overproducing
Figure 2. Direct interactions between Crn1, Arp2/3 complex, and 
actin filaments. Coomassie-stained gel of HA–Arp2/3 complex 
isolated on HA antibody–coupled beads (lane 1); 1  M Crn1 
cosediments with HA–Arp2/3 complex beads (lane 2), but not with 
control beads (lane 3). Gel migration positions are labeled for Crn1 
(arrow) and Arp2/3 complex subunits (lines). 
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Crn1, but never in control cells (
 
 
 
100 cells scored in three
separate experiments).
To define the part of Crn1 that mediates these defects, we
examined cells overproducing different Crn1 fragments
from the galactose-inducible promoter. Whereas cells over-
expressing full-length Crn1 showed growth arrest on galac-
tose media, cells carrying vector alone or pGAL-Crn1 (1–600)
were viable (Fig. 4 A). Further, these cells did not contain
the aberrant actin loop structures found in cells overexpress-
ing full-length Crn1 (unpublished data). Immunoblotting
confirmed that Crn1 and Crn1 (1–600) were overexpressed
to similar levels in these strains, well above endogenous
Crn1 expression levels (Fig. 4 C). Thus, the coiled coil do-
main is required for the growth arrest and formation of actin
loop structures caused by Crn1 overexpression. This finding
raises the possibility that interactions between the coiled coil
domain of Crn1 and the Arp2/3 complex lead to these de-
fects in cell growth and actin loop formation. We were un-
able to determine if overproduction of Crn1 (400–651) was
sufficient to cause the defects, because this construct was not
successfully overproduced; the overexpression levels of this
construct were similar to endogenous Crn1 in wild-type cells
(Fig. 4 C).
To test whether Crn1 becomes mislocalized upon overpro-
duction, we examined Crn1 localization by immunofluores-
cence in the Crn1-overexpressing cells (Fig. 5). In cells carry-
ing an empty vector, endogenous Crn1 colocalized with actin
 
patches as expected. However, in cells overproducing Crn1,
Crn1 was found to associate with actin patches and loop
structures (Fig. 5 A). Treatment of these cells with latruncu-
lin A, an actin monomer sequestering agent, caused Crn1
staining to shift to the cytoplasm, demonstrating that the lo-
calization of Crn1 to both structures depends on filamentous
actin (Fig. 5 B). Costaining with actin and Crn1 antibodies
confirmed that Crn1 localizes to the same aberrant actin
loops that form as a result of Crn1 overexpression (Fig. 5 C).
We also examined the localization of Arp2–YFP in cells
overexpressing Crn1 (Fig. 6). In control cells, Arp2–YFP lo-
calized to actin patches, similar to Arp2 immunostaining
(Moreau et al., 1996). However, in strains overproducing
Crn1, Arp2–YFP also localized to looped structures. Impor-
tantly, two other actin patch components, Abp1 and cap-
ping protein, remained localized to actin patches in cells
overexpressing Crn1 (Fig. 6). Similarly, Las17–GFP re-
mained localized to actin patches and was not recruited to
the actin loops in cells overexpressing Crn1 (unpublished
data). These data demonstrate that recruitment of Arp2 to
Crn1-induced looped structures is specific. They also pro-
vide further in vivo support for a physical interaction be-
tween Crn1 and the Arp2/3 complex.
 
Genetic interactions between 
 
CRN1
 
,
 
 ARC35
 
, and 
 
ARP2
 
Given that the lethality caused by 
 
CRN1
 
 overexpression re-
quires its coiled coil domain and that this region of Crn1 in-
Figure 3. Domain requirements of Crn1 
for association with the Arp2/3 complex 
and localization to actin patches in vivo. 
(A) Coimmunoprecipitation of Crn1 with the 
Arp2/3 complex is dependent on the Crn1 
coiled coil domain. Arp2–HA was immuno-
precipitated using anti-HA antibodies from 
lysates of crn1-null cells transformed with 
low copy plasmids expressing full-length 
Crn1, Crn1 (1–600), and Crn1 (400–651). 
Whole cell extracts and pellets from the 
immunoprecipitations were blotted 
and probed with anti-Crn1 antibodies. 
(B) Localization of full-length Crn1, Crn1 
(1–600), or Crn1 (400–651) in the same 
cells by immunofluorescence microscopy 
using anti-Crn1 antibodies. (C) Localization 
of Crn1–GFP and Crn1 (1–600)–GFP fusion 
proteins in live cells. 
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teracts with Arc35 in the two hybrid assay, we reasoned that
mutations in 
 
arc35
 
 might be able to suppress the lethal ef-
fects of 
 
CRN1
 
 overexpression. To test this hypothesis, we
used a collection of temperature-sensitive 
 
arc35
 
 alleles gen-
erated by random mutagenesis (unpublished data). We
transformed the integrated 
 
arc35
 
 mutant strains with a
GAL–
 
CRN1
 
 overexpression plasmid or vector alone. The
transformed cells were diluted serially, spotted on glucose
and galactose media, and grown for 3 d at a range of temper-
atures. Most of the 
 
arc35
 
 mutant strains, independent of 
 
CRN1
 
overexpression, exhibited normal growth at 28
 
 
 
C on glucose
medium but grew poorly, if at all, on galactose medium rela-
tive to an isogenic wild-type 
 
ARC35
 
 strain (Fig. 7 A, top).
One allele carrying pGAL-
 
CRN1
 
, 
 
arc35-26 
 
grew well on ga-
lactose. Fig. 7 A shows the data for wild-type 
 
ARC35
 
, 
 
arc35-
26
 
, and one of the many nonsuppressing 
 
arc35
 
 alleles,
 
arc35-12
 
. This result shows that 
 
arc35-26
 
 strongly sup-
presses the 
 
CRN1
 
 overexpression defects, and, reciprocally,
 
CRN1
 
 overexpression suppresses 
 
arc35-26
 
 growth defects on
galactose (compare with 
 
arc35-26
 
 carrying empty vector on
galactose; Fig. 7 A, top right).
We next explored the possibility of genetic interactions
between 
 
CRN1
 
 and the genes encoding other subunits of
the Arp2/3 complex. We performed directed crosses be-
tween a 
 
crn1
 
-null and a number of published 
 
arp2
 
 alleles,
the 
 
arc40-40
 
 allele (Tong et al., 2001), and several unpub-
lished 
 
arp2
 
 alleles (a gift from H. Xu and C. Boone, Uni-
versity of Toronto). These crosses revealed an allele-spe-
cific genetic interaction between the 
 
crn1
 
-null mutant and
 
arp2-21
 
, a temperature-sensitive mutant (Fig. 7 B). 
 
arp2-
21
 
 mutant cells exhibit normal growth at 30
 
 
 
C, are par-
tially compromised for growth at 34
 
 
 
C, and are dead at
37
 
 
 
C, whereas 
 
crn1
 
 
 
-null cells exhibit normal growth at
all temperatures. However, 
 
crn1
 
 
 
 arp2-21
 
 double mutant
cells are severely compromised for growth at 34
 
 
 
C.
Rhodamine phalloidin staining showed that 
 
crn1
 
 
 
 arp2-21
 
cells have similar defects in actin organization (highly de-
polarized actin patches) to 
 
arp2-21
 
 cells (unpublished
data). These data, combined with the suppression analysis
above, strongly support an in vivo functional interaction
between Crn1 and the Arp2/3 complex in a similar physio-
logical process.
Figure 4. Overexpression of Crn1 is lethal and causes the formation 
of aberrant actin loop structures. (A) Growth on glucose- and 
galactose-containing media of cells carrying empty vector or 
plasmids expressing CRN1 and CRN1 (1–600) under control of the 
GAL promoter. Cells were serially diluted, spotted onto plates, and 
grown for 3 d. (B) Rhodamine phalloidin staining of abnormal actin 
structures in cells overproducing Crn1. Cells carrying pGAL-CRN1 
were grown to log phase in glucose and the expression of CRN1 
was induced by growth in galactose-containing medium for 4 h. 
Then, cells were fixed and actin organization was examined by 
rhodamine phalloidin staining. (C) Immunoblot of total cellular 
extracts from strains expressing Crn1 from a low copy plasmid 
(see Fig. 3) and induced to overexpress different Crn1 constructs by 
growth in galactose-containing medium. The blot was probed with 
rabbit anti-Crn1 antibodies.
Figure 5. Localization of overproduced Crn1 to aberrant actin 
loop structures. (A) Cells carrying pGAL-CRN1 or empty vector 
were grown to log phase in glucose medium, and then cultures 
were shifted to galactose-containing medium for 4 h to induce over-
expression of CRN1. The cells were fixed and Crn1 localization was 
determined by immunofluorescence using rabbit anti-Crn1 antibodies. 
(B) Localization of Crn1 in latrunculin A–treated cells. Cells carrying 
pGAL-CRN1 or empty vector grown as above and shifted to galactose-
containing medium for 4 h were treated for 15 min with 100  M Lat 
A dissolved in DMSO or an equal volume of DMSO. Crn1 localization 
was determined by immunofluorescence as above. (C) Coimmuno-
fluorescence of Crn1 and actin in cells overexpressing CRN1 under 
control of the GAL promoter.998 The Journal of Cell Biology | Volume 159, Number 6, 2002
The carboxy terminus of Crn1 inhibits actin nucleation 
of the Arp2/3 complex
To investigate the biochemical basis of our in vivo observa-
tions, we compared the nucleation activities of purified
Arp2/3 complex in the presence and absence of Crn1. The
polymerization of actin alone is slow (Fig. 8 A, curve F), re-
flecting an inherently poor nucleation activity of purified ac-
tin monomers. However, the addition of 20 nM Arp2/3
complex plus 200 nM activating (WA) fragment of Las17/
Bee1 (the yeast homologue of WASp) stimulated rapid actin
nucleation (Fig. 8 A, curve B). The addition of 500 nM
Crn1 greatly extended the lag phase and reduced the rate of
WA-activated Arp2/3 complex–mediated actin assembly
(Fig. 8 A, curve D). This effect is not the result of interac-
tions of Crn1 with actin, because the addition of 500 nM
Crn1 to actin alone caused a modest increase in the rate of
actin assembly, consistent with previous reports (Goode et
al., 1999). These data show that Crn1 directly inhibits the
actin nucleation activity of WA-activated Arp2/3 complex.
To define the part of Crn1 that inhibits the Arp2/3 com-
plex activity, we tested the effects of Crn1 fragments in these
assays. Truncation of the coiled coil domain (residues 601–
651) abolished the effects (Fig. 8 A, curve A), whereas a car-
boxy-terminal fragment of Crn1 (residues 400–651) showed
a similar activity to full-length Crn1 (Fig. 8 A, curve C). As
shown in Fig. 8 B, the effects of Crn1 (400–651) are dose
responsive, with a half-maximal concentration of  100 nM
(Fig. 8 C). Crn1 (400–651) also inhibited Abp1-activated
Arp2/3 complex (Fig. 8 D). Importantly, this Crn1 frag-
ment has no detectable affinity for actin (Goode et al.,
1999), indicating that inhibition is direct.
Crn1 recruits the Arp2/3 complex to the sides 
of actin filaments
What is the mechanism of Arp2/3 complex inhibition by
Crn1? We observed a two hybrid interaction between Crn1
(466–651) and Arc35/p35, and there is strong evidence that
this subunit mediates binding of the Arp2/3 complex to the
sides of actin filaments (Mullins et al., 1997; Bailly et al.,
2001; Gournier et al., 2001). Therefore, we considered the
possibility that Crn1 (400–651) interactions with Arc35
might block Arp2/3 complex association with the sides of
actin filaments to delay nucleation. However, we detected
no difference in Arp2/3 complex affinity for actin filaments
in a cosedimentation assay in the presence and absence of
Crn1 (400–651) (unpublished data). This suggests that in-
hibition does not result from blocking Arp2/3 complex in-
teractions with the sides of actin filaments. Further, inhibi-
tion does not appear to result from Crn1 interference with
activator binding to the Arp2/3 complex, because Crn1 in-
hibits the basal nucleation activity of the Arp2/3 complex, in
the absence of any activators (Fig. 9 A).
In contrast to Crn1 (400–651), full-length Crn1 actually
increased the association of the Arp2/3 complex with the
sides of actin filaments (Fig. 9 B). Purified Crn1 binds
strongly to actin filaments (Kd  10 nM) through its
Figure 6. Localization of Arp2–YFP in cells overexpressing CRN1. 
(A) Cells expressing an integrated Arp2–YFP fusion protein and 
carrying empty vector or pGAL-CRN1 were grown to log phase, and 
expression of CRN1 was induced for 4 h in galactose-containing 
medium. Arp2–YFP localization was examined in live cells by 
fluorescence microscopy. (B) Cells expressing integrated Abp1–GFP 
or Cap2–GFP fusion proteins and carrying empty vector or pGAL-
CRN1 were grown to log phase. Then, expression of CRN1 was 
induced for 4 h in galactose-containing medium. Abp1–GFP and 
Cap2–GFP localization was examined in live cells by fluorescence 
microscopy.
Figure 7. Genetic interactions between Crn1 and the Arp2/3 
complex. (A) Suppression of CRN1 overexpression growth defects 
by arc35-26. A collection of 17 mutant arc35 alleles and a congenic 
wild-type strain were transformed with pGAL-CRN1 or empty vector 
alone. Transformants were serially diluted, spotted onto glucose- 
and galactose-containing media, and grown for 3 d at 28 C. Data 
are shown for wild-type ARC35, arc35-26, and arc35-12 strains. 
(B) Synthetic growth defects between a crn1-null mutation and the 
arp2-21 temperature-sensitive mutant. Cells were grown to log 
phase, serially diluted, spotted onto glucose-rich plates, and grown 
for 3 d at 30 C or 34 C. Coronin inhibition of Arp2/3 complex | Humphries et al. 999
amino terminus (Goode et al., 1999), whereas yeast Arp2/3
complex binds weakly to the sides of actin filaments (Kd
 2–3  M), similar to Arp2/3 complex isolated from other
species (discussed in Goode et al., 2001). As shown in Fig.
9 B, Arp2/3 complex cosedimentation with 2  M actin fil-
aments increases significantly in the presence of 2  M
Crn1. Thus, Crn1 recruits the Arp2/3 complex to the sides
of actin filaments. Further, these effects do not result from
actin filament bundling by Crn1, because a different actin
bundling protein (Sac6/fimbrin) had no effect in this assay
(unpublished data).
We also tested the ability of Crn1 to inhibit Arp2/3-medi-
ated actin assembly in the presence of preformed actin fila-
ments. When 500 nM preassembled actin filaments was
added to 2  M actin monomers and WA-activated Arp2/3
complex, the lag phase was nearly eliminated (Fig. 9 C,
curve A), consistent with previous reports (Machesky et al.,
1997). When we further added 500 nM Crn1 (400–651), a
concentration that dramatically inhibits Arp2/3 complex in
the absence of filaments (Fig. 8 A, compare curves B and C),
there was little, if any, inhibition detected (Fig. 9 C, curve
B). Thus, Crn1 suppresses the Arp2/3 complex specifically
in the absence of actin filaments.
Discussion
Coronin is a ubiquitous component of the eukaryotic actin
cytoskeleton and localizes to sites of dynamic actin assembly
in cells (for review see de Hostos, 1999). However, since its
identification almost 10 yr ago, the precise function of coro-
Figure 8. The coiled coil domain of Crn1 inhibits Arp2/3 complex–mediated actin nucleation. (A) Inhibition of Arp2/3 complex by the 
carboxy terminus of Crn1. Assembly kinetics for 2  M monomeric actin in the presence or absence of 20 nM Arp2/3 complex, 200 nM WA 
fragment of Las17/Bee1, and 500 nM Crn1 or Crn1 fragments. Curve A, Arp2/3 complex, WA, and Crn1 (1–600); curve B, Arp2/3 complex 
and WA; curve C, Arp2/3 complex, WA, and 500 nM Crn1 (400–651); curve D, Arp2/3 complex, WA, and 500 nM Crn1 (1–651); curve E, 
Arp2/3 complex; curve F, actin alone. (B) Dose-responsive inhibition of the Arp2/3 complex by Crn1 (400–651). The graph shows assembly of 
2  M monomeric actin (10% pyrene labeled) in the presence of 20 nM Arp2/3 complex, 200 nM WA, and 0–1,000 nM Crn1 (400–651). 
Curve A, no Crn1 added; curve B, 67.5 nM Crn1 (400–651); curve C, 250 nM Crn1 (400–651); curve D, 500 nM Crn1 (400–651); curve E, 
1,000 nM Crn1 (400–651); curve F, actin alone. (C) Graph showing the concentration-dependent effects of Crn1 (400–651) on the rate of 
Arp2/3 complex–nucleated actin assembly; the data is from B (see Materials and methods). (D) Crn1 inhibits Abp1-stimulated Arp2/3 complex 
activity. Monomeric actin (2  M) assembled with 50 nM Arp2/3 complex, 500 nM Crn1 (400–651), 50 nM Abp1, or 200 nM WA. Curve A, 
Arp2/3 and Abp1; curve B, Arp2/3 and WA; curve C, Arp2/3, WA, and Crn1 (400–651); curve D, Arp2/3, Abp1, and Crn1 (400–651); curve E, 
Arp2/3; curve F, actin alone.1000 The Journal of Cell Biology | Volume 159, Number 6, 2002
nin in the actin cytoskeleton has remained poorly under-
stood. Here, we have made an important step toward defin-
ing the cellular function of yeast coronin (Crn1). We show
that (a) Crn1 and the Arp2/3 complex physically and func-
tionally interact in vivo, (b) the interaction is mediated by
the coiled coil domain of Crn1, which is evolutionarily con-
served, and (c) Crn1 strongly modulates Arp2/3 complex ac-
tivity, inhibiting actin nucleation in the absence of pre-
formed actin filaments. This work defines a new mode of
regulation for the Arp2/3 complex and identifies Crn1 as the
first direct inhibitor of the Arp2/3 complex.
Physical and genetic interactions between Crn1 and 
the Arp2/3 complex
We have found a strong physical association between Crn1
and the Arp2/3 complex, as demonstrated by a variety of as-
says, including comigration on sucrose gradients, coimmu-
noprecipitation, two hybrid analysis, and direct binding of
purified proteins. These interactions and the effects of Crn1
on Arp2/3 complex activity are mediated by the coiled coil
domain of Crn1. Our attempts by blot overlay assays to map
the specific subunit(s) of the Arp2/3 complex that binds
Crn1 have been unsuccessful thus far (unpublished data).
However, our two hybrid data suggest that Arc35 may be an
important target of Crn1 binding, and this is supported by
the observation that an arc35 allele suppresses the growth
defects caused by CRN1 overexpression.
Over 50% of the cellular Crn1 is bound to the Arp2/3
complex, suggesting that the cellular functions of Crn1 and
the Arp2/3 complex are closely linked. This is supported by
in vivo evidence, including synthetic defects between crn1-
null mutants and arp2-21 and suppression by arc35-26 of
defects caused by CRN1 overexpression. Further, localiza-
tion of Crn1 to cortical actin patches in vivo depends on
both its actin binding domain and its Arp2/3 complex–
interacting coiled coil domain. A similar observation was
made in cultured Xenopus cells, where deletion of the coiled
coil domain caused mislocalization of coronin (Mishima and
Nishida, 1999). Because coronin forms coiled coil–depen-
dent homodimers in vitro (Goode et al., 1999; Asano et al.,
2001), it was postulated that coronin dimerization may be
necessary for localization. However, our findings raise the
possibility that interactions of the coiled coil domain with
the Arp2/3 complex may contribute to localization. Impor-
tantly, these models are not mutually exclusive; coronin lo-
calization may require both homodimerization and interac-
tions with the Arp2/3 complex. Another important point
raised here and in the above-mentioned study is that actin
binding alone is not sufficient to localize coronin to actin fil-
ament structures in vivo. Therefore, associations between
coronin and actin may be regulated in vivo.
A mechanism for Crn1 inhibition 
of Arp2/3 complex activity
We found that Crn1 inhibits WA-activated Arp2/3-medi-
ated actin nucleation and that these effects are dose respon-
sive and mediated by the Crn1 coiled coil domain. The
addition of 0.5  M Crn1 (400–651) virtually abolishes
WA- and Abp1-activated Arp2/3 complex activity. Impor-
tantly, this activity is independent of Crn1 interactions with
actin, because Crn1 (400–651) has no actin binding affinity
(Goode et al., 1999). Therefore, the inhibition of the Arp2/3
complex by Crn1 is direct.
To explore the mechanism of inhibition, it is helpful to
review current models for Arp2/3 complex activation (for re-
views see Cooper et al., 2001; Borths and Welch, 2002;
Kreishman-Deltrick and Rosen, 2002). Recently, the crystal
structure of the inactive Arp2/3 complex and cryo-electron
Figure 9. Crn1 recruits the Arp2/3 complex to the sides of actin 
filaments. (A) Assembly kinetics of 2  M monomeric actin (10% 
pyrene labeled) in the presence or absence of 50 nM Arp2/3 
complex and 500 nM Crn1 (400–651). Curve A, Arp2/3 complex; 
curve B, actin alone; curve C, Crn1 (400–651); curve D, Arp2/3 
complex and Crn1 (400–651). (B) Coomassie-stained gel of pellets 
and supernatants from cosedimentation assays containing 2  M 
F-actin, 0.5  M Arp2/3 complex, and/or 2  M full-length Crn1. 
(C) The addition of preformed actin filaments overrides Crn1 inhibition. 
Assembly kinetics for 2  M monomeric actin plus 0.5  M preformed 
actin filaments, with 20 nM Arp2/3 complex, 200 nM WA fragment 
of Las17/Bee1, and/or 500 nM Crn1 (400–651). Curve A, F-actin, 
Arp2/3, and WA; curve B, Arp2/3, WA, and Crn1 (400–651); curve 
C, 500 nM Crn1 (400–651); curve D, F-actin. Coronin inhibition of Arp2/3 complex | Humphries et al. 1001
micrograph structures of the activated complex alone and at
filament branch points were reported (Robinson et al.,
2001; Volkmann et al., 2001). Together, these studies sug-
gest that association of the Arp2/3 complex with the sides of
actin filaments and interactions with an activator converge,
inducing allosteric changes in the complex that reposition
Arp2 and Arp3 into a nucleation-competent actin-like
dimer. The p35/Arc35 subunit is strongly implicated in
physically linking the Arp2/3 complex to the sides of actin
filaments (Mullins et al., 1997; Bailly et al., 2001; Gournier
et al., 2001). Thus, interactions between p35 and the side of
a filament may transduce one set of conformational changes,
while interactions between an activator and other subunits
of the complex may transduce a complementary set of con-
formational changes.
Initially, we considered a simple model for inhibition by
Crn1, in which Crn1 competes with and displaces activators
from the Arp2/3 complex. However, our results are incon-
sistent with this model. First, Crn1 suppresses the inherent
actin nucleation of the Arp2/3 complex alone, in the absence
of any activators. Second, Crn1 does not have an acidic “A”
motif, found in and required for association with the Arp2/3
complex in all known activators (for review see Cooper et
al., 2001). Third, Crn1 interacts genetically and by two hy-
brid assay with p35/Arc35, in contrast to activators, which
are implicated in binding to four different subunits: Arp2,
Arp3, p40/Arc40, and p21/Arc18 (Mullins et al., 1997; Ma-
chesky and Insall, 1998; Zalevsky et al., 2001). Fourth, in-
creasing the concentration of WA in the reactions fails to
override Crn1 inhibition (unpublished data). Thus, all of
our data point to a functional interaction between the coiled
coil domain of Crn1 and the p35 subunit of the Arp2/3
complex, via a distinct interface from the activators.
A second model we considered for inhibition was that
Crn1 (400–651) might interfere with Arp2/3 complex bind-
ing to the sides of actin filaments. However, Crn1 (400–651)
did not affect Arp2/3 complex association with filament sides,
and, in fact, full-length Crn1 increased association of the
Arp2/3 complex with the sides of actin filaments (Fig. 2 B).
What does the arc35-26 suppression data tell us about the
mechanism of inhibition? The allele-specific inhibition of
CRN1 overexpression defects strengthens our hypothesis
that Crn1 interactions with the Arp2/3 complex occur
through the Arc35/p35 subunit. Intriguingly, arc35-26 sup-
presses the growth defects associated with Crn1 overexpres-
sion, and, reciprocally, CRN1 overexpression suppresses the
growth defects of arc35-26. This cosuppression suggests a
highly specific functional interaction between Crn1 and
Arc35. In future work, isolating the Arp2/3 complex from
arc35-26 mutant cells and studying its activities may provide
valuable insights into Crn1 action. In addition, defining the
residues in p35/Arc35 that mediate Crn1 interactions may
lend important clues to the mode of inhibition.
The cellular role of Crn1 in regulating 
the Arp2/3 complex
We have shown that Crn1 inhibits the actin nucleation ac-
tivity of the Arp2/3 complex specifically in the absence of
actin filaments via its coiled coil domain and recruits the
Arp2/3 complex to the sides of actin filaments via its actin
binding domain. Both of these activities may be used in vivo
to direct the Arp2/3 complex activity to the sides of preexist-
ing actin filaments, promoting the formation of filament
networks. Such a function might be important during cellu-
lar processes that rely on the rapid formation of actin net-
works, including cell locomotion and intracellular transport
of vesicles and organelles. Consistent with this possibility,
loss of coronin function in Dictyostelium and Xenopus cells
has been shown to cause defects in cell migration and/or en-
docytosis (de Hostos et al., 1993; Mishima and Nishida,
1999). Next, it will be important to assess whether coronin–
Arp2/3 complex interactions are conserved in other organ-
isms and determine the cellular consequences of disrupting
such interactions. Already, there are indications that the
interaction may be conserved, because substoichiometric
amounts of coronin have been shown to copurify with the
Arp2/3 complex from human neutrophils (Machesky et al.,
1997). Perhaps the most significant challenge for the future
will be to determine how the Arp2/3 complex integrates so
many different signals, from (a) multiple activators, (b)
coronin, and (c) binding to the side of an actin filament, to
spatially and temporally control actin nucleation in the cell.
Materials and methods
Strains and media
The Saccharomyces cerevisiae strains used in this study are listed in Table
I. Standard methods were used to generate strains with integrated tags
(GFP and HA epitope) at the carboxy termini of CRN1 and ARP2 and a
strain with a GFP tag integrated after residue 600 in CRN1 (Longtine et al.,
1998). A strain with a CRN1 gene deletion and an HA epitope tag inte-
grated at the carboxy terminus of ARP2 (BGY704) was generated by cross-
ing strains BGY26 and BAY1412. The resulting diploids were sporulated,
tetrads were dissected, and haploids with the BGY704 genotype were se-
lected. The presence of the ARP2–HA epitope tag and loss of the CRN1
gene were confirmed by immunoblotting with anti-Crn1 and anti-HA anti-
bodies. Standard methods were used for growth and transformation of
yeast (Guthrie and Fink, 1991). For yeast growth assays, cultures were
grown to log phase, serially diluted, spotted on plates, and grown for 3 d.
Plasmid construction
All plasmids used in this study are listed in Table II. To express full-length
Crn1 and Crn1 (1–600) on CEN plasmids under the control of the CRN1
promoter, we constructed pBG290 and pBG291 and pBG296, respec-
tively. The designated regions of the CRN1 open reading frame with 300
bp of 5  untranslated sequence upstream were PCR amplified using high fi-
delity polymerase and subcloned into the BamH1–Not1 sites of pRS316.
To express different parts of Crn1 in yeast, we constructed pBG226,
pBG289, pBG290, and pBG291 by subcloning BamH1–Nsi1 CRN1 frag-
ments from plasmids pBG203 and pBG206, respectively, into p425GAL1
and p415MET25. For overexpression of full-length Crn1, Crn1 (1–600), or
Crn1 (400–651) under control of the GAL promoter, we constructed
pBG222, pBG223, and pBG224. The designated regions of the CRN1
open reading frame were amplified by PCR using high fidelity polymerase
and subcloned into BamH1–Not1 sites of p425GAL1 or p426GAL1. For
two hybrid analysis, an Arc35 insert was excised as a BamH1–Xho1 frag-
ment from pEG202-END9 (a gift from C. Schaerer-Brodbeck, University of
Basel, Basel, Switzerland) and cloned into BamH1–Sal1 sites of pAS2 to
yield pAS2-ARC35. The plasmid was shown to express a functional fusion
protein by complementation of the 37 C growth defect of arc35-1
(Schaerer-Brodbeck and Riezman, 2000). All plasmids were sequenced to
confirm that the CRN1 coding sequences contained no mutations.
Antibody preparation and immunoblotting
Two different Crn1 antibodies were used, a mouse polyclonal anti-Crn1
antibody previously described (Goode et al., 1999) and a rabbit polyclonal
anti-Crn1 antibody generated here (Faculty of Medicine, University of Tor-
onto). The rabbits were immunized with a GST–Crn1 fusion protein ex-
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antibodies were affinity purified from serum (Measday et al., 1994). Like
the mouse anti-Crn1 antibody, the rabbit anti-Crn1 antibody recognizes an
85-kD band on blots of wild-type total cellular protein that is absent from
crn1-null lanes (not depicted). Proteins were detected on blots using
1:1,000 mouse anti-Crn1, 1:5,000 rabbit anti-Crn1, and 1:1,000 rabbit
anti-Arp2 (Moreau et al., 1996). HA–Arp2 was detected using 1:10,000
mouse anti-HA antibody conjugated to HRP (Covance; Denver, CO). For
all other blots, 1:10,000 HRP-conjugated secondary antibody was used.
Signals were detected by ECL from Amersham Biosciences.
Protein purification
The Arp2/3 complex was purified from yeast (Goode et al., 2001). Crn1,
Crn1 (1–600), and Crn1 (400–651) were purified from E. coli (Goode et al.,
1999). The carboxy-terminal WA fragment of Las17/Bee1 was purified from
E. coli (Winter et al., 1999). Unlabeled and pyrene-labeled rabbit skeletal
muscle actin were purchased from Cytoskeleton, Inc. Monomeric actin was
reconstituted from a lyophilized state as per the manufacturer’s instructions,
diluted to 25–50  M in G-buffer (5 mM Tris-HCl , pH 7.5, 0.2 mM DTT, 0.2
mM ATP, 0.2 mM CaCl2), incubated overnight on ice, and cleared by cen-
trifugation for 1 h at 4 C, 90,000 rpm in a TLA100 rotor (Beckman Coulter).
Sucrose gradient fractionation of yeast lysates
11-ml sucrose gradients (3–30%) were poured in 12-ml ultra clear tubes
for an SW41 rotor (Beckman Coulter). Crude cell lysates were prepared
from wild-type and crn1-null yeast as previously described (Goode et al.,
1999). Lysates were precleared by centrifugation for 15 min, 70,000 rpm,
4 C in a TLA100.3 rotor (Beckman Coulter). 400  l supernatant or high
molecular weight gel filtration size standards (Amersham Biosciences)
were layered over each gradient. Samples were centrifuged for 15 h at
34,000 rpm, 4 C in an SW41 rotor, and 0.4-ml fractions were collected.
Samples of each fraction were run on SDS-PAGE gels, blotted, and probed
with antibodies to determine the positions of proteins in the gradients.
Coimmunoprecipitation assays
For coimmunoprecipitation assays, we used yeast strains with an inte-
grated carboxy-terminal 3xHA epitope tag on ARP2. Cells were grown to
log phase, washed, frozen, and lysed as previously described (Goode et
al., 1999). 1 g of cell lysate was added to 1 ml HEK buffer (20 mM Hepes,
pH 7.5, 1 mM EDTA, 50 mM KCl), supplemented with 1mM DTT, 0.1%
NP-40 detergent, and a standard cocktail of protease inhibitors (Goode et
al., 1999). The lysate was thawed to 4 C and precleared by centrifugation
for 15 min at 4 C, 80,000 rpm in a TLA100.3 rotor. The supernatant was
harvested and preabsorbed with CL4B protein A–Sepharose (Amersham
Biosciences) for 1 h at 4 C. The beads were pelleted and 500  l of super-
natant was added to 2.5  l of HA.11 monoclonal antibody (5–7 mg/ml as-
cites fluid; Covance) and incubated for 1 h at 4 C. Next, we added 20  l of
CL4B protein A–Sepharose (preswollen in HEK buffer) and incubated for
1 h at 4 C with mixing. The beads were washed twice in HEK buffer and
then once in HEK buffer supplemented with 0.5% NP-40, and samples
were prepared in SDS sample buffer for immunoblotting.
Table I. Strains used in this study
Name Genotype Source
BGY006 MAT , his3-11,15, ura3-52, leu2-3,112, ade2-1, trp1-1, GAL
 , CRN1-GFP::HIS3MX6 This study
BGY008 MAT , his3-11,15, ura3-52, leu2-3,112, ade2-1, trp1-1, GAL
 , CRN1(1-600)-GFP::HIS3MX6 This study
BGY026 MAT , his3-11,15, ura3-52, leu2-3,112, ade2-1, trp1-1, GAL
 , ARP2-3xHA::HIS3MX6 This study
BGY029 MAT , his3-11,15,  leu2-3,112, ade2-1, trp1-1, GAL
 , ura3 ::ACT1pr-ABP1-GFP::URA3 This study
BGY046 MATa, leu2-3,112, ura3-52, ade2-101, ade3-130, crn1 ::LEU2 This study
BGY654 MAT , ARP2-TEV-3xHA::HIS3MX6, leu2D::ARC35::LEU2, arc35 ::KANMX6, ura3-52, his3 200 D. Robins
a
BGY661 MAT , ARP2-TEV-3xHA::HIS3MX6, leu2 ::arc35-12::LEU2, arc35 ::KANMX6, ura3-52, his3 200 D. Robins
a
BGY670 MAT , ARP2-TEV-3xHA::HIS3MX6, leu2 ::arc35-26::LEU2, arc35 ::KANMX6, ura3-52, his3 200 D. Robins
a
BGY704 MAT , his3-11,15, ura3-52, leu2-3,112, ade2-1, trp1-1, psi
 , ssd
 , GAL
 , ARP2-3xHA::HIS3MX6, crn1 ::
KANMX6
This study
BGY714 MATa, ARP2-YFP::HIS3MX6, ura3-52, his3 200, ade2-1, leu2-3,112 This study
BGY721 MAT , arp2-21::URA3, crn1 ::KANMX6, leu2 0 This study
BAY263 MATa, trp1 63, GAL2
 , ura3-52, lys2-801, ade2-107, his3 200, leu2- 1 Measday et al., 1994
BAY1355 MATa, crn1 ::URA3, trp 63, GAL2
 , ura3-52, lys2-801, ade2-107, his3 200, leu2- 1 This study
BAY1412 MATa, crn1 ::KANMX6, his3 1, leu2 0, met15 0, ura3 0 Research Genetics
BAY1674 MAT , arp2-21::URA3, mfa1 ::MFA1pr-HIS3, can1 , his3 1, leu2 0, MET15
 , lys2 0 C. Boone
b
BAY3029 MAT , arc40-40::URA3, mfa1 ::MFAprHIS3, can1 , his3 1, leu2 0, MET15
 , lys2 0 Tong et al., 2001
YJC1265 Ura3-52/ura3-53, leu2-3,112/leu2-3,112, trp1 ::CAP2-GFP::TRP1, trp1 ::CAP2-GFP::TRP1 Waddle et al., 1996
aBrandeis University.
bUniversity of Toronto.
Table II. Plasmids used in this study
Name Insert Vector Reference
pBG203 GST–CRN1 pGAT2 Goode et al., 1999
pBG205 GST–CRN1 (400–651) pGAT2 Goode et al., 1999
pBG206 GST–CRN1 (1–600) pGAT2 Goode et al., 1999
pBG222 CRN1 pRS426GAL1 This study
pBG223 CRN1 (1–600) pRS426GAL1 This study
pBG224 CRN1 (400–651) pRS426GAL1 This study
pBG290 CRN1 pRS415MET25 This study
pBG291 CRN1 (1–600) pRS415MET25 This study
pBG294 CRN1 pRS316 This study
pBG295 CRN1 (1–600) pRS316 This study
pBG298 CRN1 (400–651) pRS415MET25 This study
pAS2  ::ARC35 ARC35 pAS2   This study Coronin inhibition of Arp2/3 complex | Humphries et al. 1003
Binding interactions between Crn1 and the Arp2/3 complex
To test direct binding between Crn1 and the Arp2/3 complex, we assayed
the cosedimentation of purified Crn1 with purified HA-tagged yeast Arp2/3
complex immobilized on beads. The Arp2/3 complex–loaded beads were
prepared as previously described (Goode et al., 2001), yielding a bead sus-
pension of 1  M Arp2/3 complex. 10  l of Arp2/3-loaded beads or control
beads (no Arp2/3) was included in a 100- l reaction in HEK buffer con-
taining 1  M Crn1. The final concentration of the Arp2/3 complex in the
reactions was 0.1  M. Reactions were incubated for 20 min at 4 C, the
beads were washed, and the bound proteins were removed with SDS sam-
ple buffer (without reducing agent). Samples were run on 12% SDS-PAGE
gels and stained with Coomassie blue.
Two hybrid analysis
A yeast cDNA library in pGAD-GH was transformed into the Y190 yeast
strain containing pAS2-ARC35, and a nonsaturating Gal two hybrid screen
was performed as previously described (Madania et al., 1999). Transfor-
mants were selected on  TRP,  LEU,  HIS,  30 mM 3-aminotriazole
medium, and 24 clones were isolated. After a series of secondary tests,
four clones remained, two of which were found to contain a fragment of
Crn1 encoding its carboxy-terminal 186 residues (466–651).
Fluorescence light microscopy
Actin and Crn1 organization was examined in cells overproducing full-
length Crn1, Crn1 (1–600), and Crn1 (400–651) under control of the
GAL1/10 promoter, from plasmids pBG222, pBG223, and pBG224. Cells
were grown at 30 C in selective glucose medium to early log phase,
washed, transferred to selective galactose medium, grown for 4 h at 30 C,
fixed, and prepared for immunofluorescence (Ayscough and Drubin,
1997; Lee et al., 1998). To disrupt the actin cytoskeleton in cells, log-
phase yeast cultures were treated with 100  M latrunculin A for 15 min
before chemical fixation. We also determined the localization of full-
length Crn1, Crn1 (1–600), and Crn1 (400–651) expressed in cells from
low copy plasmids (pBG290, pBG291, and pBG298) under the control of
the MET25 promoter (Fig. 3 B). Similar results were obtained for low copy
plasmids expressing full-length Crn1 and Crn1 (1–600) under the control
of its own promoter: pBG294 and pBG295 (not depicted). For immunoflu-
orescence detection of Crn1 and actin, we used a 1:500 dilution of rabbit
anti-Crn1 and a 1:2,000 dilution of guinea pig anti-Act1 (Mulholland et al.,
1994). Cells were imaged on a Leica DM-LB microscope. Images were
captured with a Micromax 1300y high-speed digital camera (Princeton In-
struments) and analyzed with Metaview software (Universal Imaging
Corp.). The localization of GFP and YFP was examined in yeast cells
grown to log phase.
Actin assembly kinetics
Actin assembly was monitored by the pyrene–actin fluorescence assay as
previously described (Goode et al., 2001), using a final concentration of 2
 M actin in 70- l reactions unless otherwise indicated. In brief, 56.5  l of
monomeric actin (10% pyrene-labeled, 90% unlabeled) in G buffer was
mixed with 10  l HEKG5 buffer (HEK buffer   5% glycerol) or different
combinations of proteins in HEKG5 buffer. The reaction was mixed imme-
diately with 3.5  l 20  initiation buffer (1 M KCl, 40 mM MgCl2, 10 mM
ATP) in a quartz fluorometry cuvette (3-mm light path; Hellma). Pyrene–
actin fluorescence was monitored by excitation at 365 nM and emission at
407 nM in a fluorescence spectrophotometer (Photon Technology Interna-
tional) held at the constant temperature of 25 C. For seeded reactions, ac-
tin was preassembled to steady state for 1 h. Then, 2  M monomeric actin
(10% pyrene labeled) was mixed with 500 nM preassembled actin fila-
ments in the presence or absence of different proteins.
Actin filament recruitment assays
Binding of the Arp2/3 complex to the sides of actin filaments was mea-
sured as previously described (Goode et al., 2001). In Fig. 9 B, 2  M full-
length Crn1 and/or 0.5  M Arp2/3 complex were added to 2  M preas-
sembled actin filaments. After a 20-min incubation, the reactions were
centrifuged for 20 min in a TLA100 rotor (Beckman Coulter). Equal loads
of pellets and supernatants were fractionated on 12% SDS-PAGE gels and
stained with Coomassie blue.
We are very grateful to A. Rodal for advice throughout the study, C.
Boone, S. Hippenmeyer and H. Riezman (University of Basel), D. Robins,
and H. Xu for sharing unpublished reagents, J. Wong, P. Dumoulin, and S.
Thuault for technical assistance, and C. Boone, F. Chang, A. Goodman, D.
Pellman, A. Rodal, and I. Sagot for helpful comments on the manuscript.
This work was supported by an award from the Canadian Institutes of
Health Research to C. Humphries, an operating grant from the National
Cancer Institute of Canada with funds from the Canadian Cancer Society to
B. Andrews, support from the Centre National de Recherche Scientifique
and the Association pour la Recherche sur le Cancer to B. Winsor, and
a grant from the National Institutes of Health (NIIH) to G. Barnes
(GM47842). B. Goode was supported by a Pew Scholars award, a Basil
O’Conner award, and the NIH (GM63691).
Submitted: 26 June 2002
Revised: 30 September 2002
Accepted: 7 November 2002
References
Asano, S., M. Mishima, and E. Nishida. 2001. Coronin forms a stable dimer
through its C-terminal coiled coil region: an implicated role in its localiza-
tion to cell periphery. Genes Cells. 6:225–235.
Ayscough, K.R., and D.G. Drubin. 1997. Immunofluorescence microscopy of
yeast cells. In Cell Biology, A Laboratory Handbook. Vol. 2. J. Celis, editor.
Academic Press. San Diego, CA. 477–485.
Bailly, M., I. Ichetovkin, W. Grant, N. Zebda, L.M. Machesky, J.E. Segall, and J.
Condeelis. 2001. The F-actin side binding activity of the Arp2/3 complex is es-
sential for actin nucleation and lamellipod extension. Curr. Biol. 11:620–625.
Borths, E.L., and M.D. Welch. 2002. Turning on the Arp2/3 complex at atomic
resolution. Structure (Camb). 10:131–135.
Cooper, J.A., M.A. Wear, and A.M. Weaver. 2001. Arp2/3 complex: advances on
the inner workings of a molecular machine. Cell. 107:703–705.
de Hostos, E.L. 1999. The coronin family of actin-associated proteins. Trends Cell
Biol. 9:345–350.
de Hostos, E.L., C. Rehfuess, B. Bradtke, D.R. Waddell, R. Albrecht, J. Murphy, and
G. Gerisch. 1993. Dictyostelium mutants lacking the cytoskeletal protein coronin
are defective in cytokinesis and cell motility. J. Cell Biol. 120:163–173.
Goode, B.L., and A.A. Rodal. 2001. Modular complexes that regulate actin assem-
bly in budding yeast. Curr. Opin. Microbiol. 4:703–712.
Goode, B.L., J.J. Wong, A.C. Butty, M. Peter, A.L. McCormack, J.R. Yates, D.G.
Drubin, and G. Barnes. 1999. Coronin promotes the rapid assembly and
cross-linking of actin filaments and may link the actin and microtubule cy-
toskeletons in yeast. J. Cell Biol. 144:83–98.
Goode, B.L., A.A. Rodal, G. Barnes, and D.G. Drubin. 2001. Activation of the
Arp2/3 complex by the actin filament binding protein Abp1p. J. Cell Biol.
153:627–634.
Gournier, H., E.D. Goley, H. Niederstrasser, T. Trinh, and M.D. Welch. 2001.
Reconstitution of human Arp2/3 complex reveals critical roles of individual
subunits in complex structure and activity. Mol. Cell. 8:1041–1052.
Guthrie, C., and R. Fink. 1991. Guide to yeast genetics and molecular biology.
Methods Enzymol. 194:1–933.
Heil-Chapdelaine, R.A., N.K. Tran, and J.A. Cooper. 1998. The role of Saccharo-
myces cerevisiae coronin in the actin and microtubule cytoskeletons. Curr.
Biol. 8:1281–1284.
Higgs, H.N., and T.D. Pollard. 2001. Regulation of actin filament network forma-
tion through ARP2/3 complex: activation by a diverse array of proteins.
Annu. Rev. Biochem. 70:649–676.
Kreishman-Deltrick, M., and M.K. Rosen. 2002. Ignition of a cellular machine.
Nat. Cell Biol. 4:E31–E33.
Lee, J., K. Colwill, V. Aneliunas, C. Tennyson, L. Moore, Y. Ho, and B. Andrews.
1998. Interaction of yeast Rvs167 and Pho85 cyclin-dependent kinase com-
plexes may link the cell cycle to the actin cytoskeleton. Curr. Biol. 8:1310–1321.
Longtine, M.S., A. McKenzie III, D.J. Demarini, N.G. Shah, A. Wach, A. Brachat,
P. Philippsen, and J.R. Pringle. 1998. Additional modules for versatile and
economical PCR-based gene deletion and modification in Saccharomyces
cerevisiae. Yeast. 14:953–961.
Machesky, L.M., and R.H. Insall. 1998. Scar1 and the related Wiskott-Aldrich
syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3
complex. Curr. Biol. 8:1347–1356.
Machesky, L.M., E. Reeves, F. Wientjes, F.J. Mattheyse, A. Grogan, N.F. Totty, A.L.
Burlingame, J.J. Hsuan, and A.W. Segal. 1997. Mammalian actin-related pro-
tein 2/3 complex localizes to regions of lamellipodial protrusion and is com-
posed of evolutionarily conserved proteins. Biochem. J. 328:105–112.
Madania, A., P. Dumoulin, S. Grava, H. Kitamoto, C. Scharer-Brodbeck, A. Sou-
lard, V. Moreau, and B. Winsor. 1999. The Saccharomyces cerevisiae homo-
logue of human Wiskott-Aldrich syndrome protein Las17p interacts with
the Arp2/3 complex. Mol. Biol. Cell. 10:3521–3538.1004 The Journal of Cell Biology | Volume 159, Number 6, 2002
Measday, V., L. Moore, J. Ogas, M. Tyers, and B. Andrews. 1994. The PCL2
(ORFD)-PHO85 cyclin-dependent kinase complex: a cell cycle regulator in
yeast. Science. 266:1391–1395.
Mishima, M., and E. Nishida. 1999. Coronin localizes to leading edges and is in-
volved in cell spreading and lamellipodium extension in vertebrate cells. J.
Cell Sci. 112:2833–2842.
Moreau, V., A. Madania, R.P. Martin, and B. Winson. 1996. The Saccharomyces
cerevisiae actin-related protein Arp2 is involved in the actin cytoskeleton. J.
Cell Biol. 134:117–132.
Mulholland, J., D. Preuss, A. Moon, A. Wong, D. Drubin, and D. Botstein. 1994.
Ultrastructure of the yeast actin cytoskeleton and its association with the
plasma membrane. J. Cell Biol. 125:381–391.
Mullins, R.D., W.F. Stafford, and T.D. Pollard. 1997. Structure, subunit topol-
ogy, and actin-binding activity of the Arp2/3 complex from Acanthamoeba.
J. Cell Biol. 136:331–343.
Mullins, R.D., J.A. Heuser, and T.D. Pollard. 1998. The interaction of Arp2/3
complex with actin: nucleation, high affinity pointed end capping, and for-
mation of branching networks of filaments. Proc. Natl. Adad. Sci. USA. 95:
6181–6186.
Olazabal, I.M., and L.M. Machesky. 2001. Abp1p and cortactin, new “hand-
holds” for actin. J. Cell Biol. 154:679–682.
Pruyne, D., and A. Bretscher. 2000. Polarization of cell growth in yeast. J. Cell Sci.
113:571–585.
Robinson, R.C., K. Turbedsky, D.A. Kaiser, J.B. Marchand, H.N. Higgs, S. Choe,
and T.D. Pollard. 2001. Crystal structure of Arp2/3 complex. Science. 294:
1679–1684.
Schafer, D.A. 2002. Coupling actin dynamics and membrane dynamics during en-
docytosis. Curr. Opin. Cell Biol. 14:76–81.
Schaerer-Brodbeck, C., and H. Riezman. 2000. Saccharomyces cerevisiae Arc35p
works through two genetically separable calmodulin functions to regulate
the actin and tubulin cytoskeletons. J. Cell Sci. 113:521–532.
Tong, A.H., M. Evangelista, A.B. Parsons, H. Xu, G.D. Bader, N. Page, M. Robin-
son, S. Raghibizadeh, C.W. Hogue, H. Bussey, et al. 2001. Systematic genetic
analysis with ordered arrays of yeast deletion mutants. Science. 294:2364–2368.
Volkmann, N., K.J. Amann, S. Stoilova-McPhie, C. Egile, D.C. Winter, L. Hazel-
wood, J.E. Heuser, R. Li, T.D. Pollard, and D. Hanein. 2001. Structure of
Arp2/3 complex in its activated state and in actin filament branch junctions.
Science. 293:2456–2459.
Waddle, J.A., T.S. Karpova, R.H. Waterston, and J.A. Cooper. 1996. Movement
of cortical actin patches in yeast. J. Cell Biol. 132:861–870.
Winter, D.C., E.Y. Choe, and R. Li. 1999. Genetic dissection of the budding yeast
Arp2/3 complex: a comparison of the in vivo and structural roles of individ-
ual subunits. Proc. Natl. Acad. Sci. USA. 96:7288–7293.
Zalevsky, J., L. Lempert, H. Kranitz, and R.D. Mullins. 2001. Different WASP
family proteins stimulate different Arp2/3 complex-dependent actin-nucle-
ating activities. Curr. Biol. 11:1903–1913.